Clinical Trial Update: Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 [Phase 3]

View source ↗

Summary

A Phase 3 trial update for intravenous Trappsol Cyclo in pediatric and adult Niemann-Pick disease type C1 patients; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type C1

Drugs mentioned

• Trappsol Cyclo (Hydroxypropyl-β-cyclodextrin)

Snippet

Sponsor: Cyclo Therapeutics, Inc. | Conditions: Niemann-Pick Disease, Type C1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING